We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,230 results
  1. Chemoprevention—Historical Perspectives and Current Trends

    Purpose of Review

    To explore the landmark clinical trials which shaped contemporary chemoprevention practice, discuss trends in chemoprevention...

    Chelsea Marin, Anna Weiss, Jessica C. Gooch in Current Breast Cancer Reports
    Article 03 January 2024
  2. Chemoprevention in hepatocellular carcinoma

    Purpose of Review

    The number of deaths due to hepatocellular carcinoma (HCC) continues to rise. Chemoprevention may be a useful strategy to prevent...

    Hiroyuki Suzuki, Cheng Han Ng, ... Daniel Q. Huang in Current Hepatology Reports
    Article 18 July 2023
  3. Cancer metastasis chemoprevention prevents circulating tumour cells from germination

    The war against cancer traces back to the signature event half-a-century ago when the US National Cancer Act was signed into law. The cancer crusade...

    **aodong **e, Yumei Li, ... Lee Jia in Signal Transduction and Targeted Therapy
    Article Open access 02 October 2022
  4. Contraception as chemoprevention of ovarian cancer in BRCA1 and BRCA2 women

    Ovarian cancer is the seventh most common cancer in women in the world, with an estimated worldwide mortality of over 207′000 women every year. This...

    Vera Loizzi, Marco Cerbone, ... Gennaro Cormio in Hormones
    Article 19 December 2023
  5. Household-level effects of seasonal malaria chemoprevention in the Gambia

    Background

    In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention (SMC) to children...

    Seyi Soremekun, Bakary Conteh, ... Chris Drakeley in Communications Medicine
    Article Open access 22 May 2024
  6. Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers

    Background

    Chemoprevention with anti-estrogens, such as tamoxifen, raloxifene or aromatase inhibitors, have been shown to reduce breast cancer risk in...

    Tarsha Jones, Thomas Silverman, ... Katherine D. Crew in BMC Medical Informatics and Decision Making
    Article Open access 04 August 2022
  7. Affect regulation as a moderator of intentions for breast cancer chemoprevention

    Women at high risk for breast cancer (BC) may consider chemoprevention for risk reduction, but uptake is low. This study examined the role of affect...

    Claire C. Conley, Doreen M. Agnese, ... Barbara L. Andersen in Journal of Behavioral Medicine
    Article 03 February 2022
  8. Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen

    Purpose

    High-risk lesions (HRLs) of the breast are an indication for chemoprevention, yet uptake is low, largely due to concerns about side effects....

    Brittany Bychkovsky, Alison Laws, ... Tari A. King in Breast Cancer Research and Treatment
    Article 04 April 2022
  9. Seasonal malaria chemoprevention in Africa and China’s upgraded role as a contributor: a sco** review

    Background

    Children under five are the vulnerable population most at risk of being infected with Plasmodium parasites, especially in the Sahel...

    Ming Xu, Yun-Xuan Hu, ... Duo-Quan Wang in Infectious Diseases of Poverty
    Article Open access 05 July 2023
  10. Cancer chemoprevention through Frizzled receptors and EMT

    Frizzled (FZD) transmembrane receptors are well known for their role in β-catenin signaling and development and now understanding of their role in...

    K. Sompel, A. Elango, ... M. A. Tennis in Discover Oncology
    Article Open access 09 September 2021
  11. Coverage of seasonal malaria chemoprevention in children aged 3 to 59 months in Burkina Faso: a nationwide cross-sectional study

    Aim

    The objective of this study was to investigate seasonal malaria chemoprevention (SMC) coverage during the 2018 campaign and to identify factors...

    Antarou Ly, Hermann Biénou Lanou, ... Maxime Koiné Drabo in Journal of Public Health
    Article 07 August 2023
  12. DNA demethylating agents for chemoprevention of oncovirus-associated leukemogenesis

    Yuta Yamamoto, Tatsuro Watanabe, ... Shinya Kimura in Leukemia
    Article 05 June 2024
  13. Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention

    To date, there is no FDA-approved chemoprevention approach for tobacco-related HNSCC. Effective chemoprevention approaches validated in sufficiently...

    Sara M. Centuori, Carlos Caulin, Julie E. Bauman in Current Treatment Options in Oncology
    Article 15 May 2021
  14. Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial

    Background

    An estimated 300,000 babies are born with sickle cell anaemia (SCA) annually. Affected children have chronic ill health and suffer...

    Thandile Nkosi-Gondwe, Bjarne Robberstad, ... Richard Idro in Trials
    Article Open access 05 April 2023
  15. Co-implementing vitamin A supplementation with seasonal malaria chemoprevention in Sokoto State, Nigeria: a feasibility and acceptability study

    Background

    Bi-annual high dose vitamin A supplements administered to children aged 6–59 months can significantly reduce child mortality, but vitamin A...

    Olusola Oresanya, Abimbola Phillips, ... Helen Smith in BMC Health Services Research
    Article Open access 05 July 2022
  16. Updates in Chemoprevention Research for Hereditary Gastrointestinal and Polyposis Syndromes

    Purpose of review

    To critically examine recently published research in the area of chemoprevention in hereditary polyposis and gastrointestinal...

    Article 28 December 2020
  17. Chemoprevention for Colorectal Cancers: Are Chemopreventive Effects Different Between Left and Right Sided Colorectal Cancers?

    Background and Aims

    Recent studies have suggested that right- and left-sided colorectal cancers (CRCs) are molecularly distinct. In this study, we...

    Junya Arai, Nobumi Suzuki, ... Mitsuhiro Fujishiro in Digestive Diseases and Sciences
    Article 01 March 2022
  18. Understanding low chemoprevention uptake by women at high risk of breast cancer: findings from a qualitative inductive study of women’s risk-reduction experiences

    Background

    Chemoprevention is one of several methods that have been developed to help high-risk women reduce their risk of breast cancer. Reasons for...

    Tasleem J. Padamsee, Megan Hils, Anna Muraveva in BMC Women's Health
    Article Open access 16 April 2021
  19. Using systems thinking to understand the scale-up and sustainability of health innovation: a case study of seasonal malaria chemoprevention processes in Burkina Faso

    Background

    Scale-up and sustainability are often studied separately, with few studies examining the interdependencies between these two processes and...

    Marietou Niang, Marie-Pierre Gagnon, Sophie Dupéré in BMC Public Health
    Article Open access 02 October 2023
Did you find what you were looking for? Share feedback.